У нас вы можете посмотреть бесплатно Clinical Research Monitoring in Drug Discovery & Invention Trials | AMSLC by CCRPS или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Clinical Research Monitoring in Drug Discovery & Invention Trials | AMSLC by CCRPS This Clinical Research Monitoring lesson examines conceptual and theoretical oversight strategies applied to drug–invention and drug–discovery interaction trials within early phase and translational clinical research environments. Clinical Research Monitoring in discovery driven trials requires a deep understanding of how preclinical rationale, mechanism of action hypotheses, and first in human risk assessments translate into compliant protocol execution and regulatory oversight. Within the Advanced Medical Science Liaison & Medical Monitor Certification (AMSLC), this module prepares Medical Monitors and Medical Science Liaisons to supervise investigational products originating from early stage drug discovery pipelines. Emphasis is placed on evaluating protocol design integrity, dose escalation safeguards, safety signal detection, pharmacodynamic endpoint validation, and risk mitigation frameworks aligned with ICH GCP E6 R3 principles. Monitoring approaches address investigator compliance, documentation accuracy, real time safety review, and sponsor level governance in Phase I and exploratory trials. The lesson connects theoretical monitoring models to real world responsibilities such as oversight of adverse event reporting, collaboration with pharmacovigilance teams, assessment of protocol deviations, review of informed consent risk language, and maintenance of inspection readiness across global sites. Participants gain structured frameworks to ensure data integrity, ethical accountability, and regulatory defensibility when managing innovative therapies transitioning from laboratory discovery into human clinical trials. As part of CCRPS’s triple accredited clinical research certification ecosystem, the AMSLC pathway delivers advanced clinical research training aligned with CPD, ACCRE, CE, NHA, and TransCelerate recognized GCP standards. The curriculum reflects real world execution across sponsors, CROs, academic institutions, and biotechnology innovators, supporting professionals seeking globally recognized clinical research certification in medical monitoring and advanced clinical trials leadership. This lesson is part of CCRPS’s role specific clinical research certification pathways, designed to match the day to day responsibilities of professionals working as CRCs, CRAs, pharmacovigilance specialists, project managers, and investigators across global trials. Learn more: https://ccrps.org Explore programs: https://app.ccrps.org Call advising: +1 801 515 4867 Educational Disclaimer: ------------------------------------- The content provided on this channel is intended for educational and informational purposes only. CCRPS does not provide medical advice, clinical treatment recommendations, legal guidance, or professional services through this content. All information shared is based on general principles of clinical research, regulatory standards, and industry practices and should not be considered a substitute for professional judgment, institutional policies, or regulatory requirements. Viewers are encouraged to consult qualified professionals, official guidelines, and regulatory authorities before applying any information in clinical, research, or professional settings. CCRPS assumes no responsibility for actions taken based on the content presented in these videos.